PTGDS and neoplasm: For example, in acute promyelocytic leukemia, tumor-derived PGD2 bound and stimulated the CRTH2 on innate lymphoid cells, activated monocytic myeloid-derived suppressor cells, and ultimately promoted tumor progression [58].